Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes

Vaccine

Volumn 31, Issue 13, 2013, Pages 1673-1679

  Hopkins, Tom Glass ^a   Wood, Nick ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

Attitude; Human papillomavirus; Vaccine

Indexed keywords

CANCER VACCINE; PLACEBO; WART VIRUS VACCINE;

ADENOCARCINOMA; ATTITUDE TO HEALTH; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; DEVELOPED COUNTRY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PRACTITIONER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; MASS IMMUNIZATION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PUBLIC OPINION; REVIEW; SCHOOL; SCHOOL HEALTH SERVICE; SEXUAL BEHAVIOR; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW (TOPIC); UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; VIRUS STRAIN; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; VACCINATION; WORLD HEALTH;

EID: 84875273245     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.028     Document Type: Review

References (89)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Ries L., Krapcho H.D., Mariotto M., Miller A., Feuer B.A., Clegg E.J., et al. SEER Cancer Statistics Review, 1975-2004 2007, National Cancer Institute, Bethesda, MD.
3. Shack L., Jordan C., Thomson C.S., Mak V., Moller H. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer 2008, 8:271.
4. Peto J., Gilham C., Fletcher O., Matthews F.E. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004, 364(9430):249-256.
5. Moser K., Patnick J., Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ 2009, 338:b2025.
6. Downs L.S., Smith J.S., Scarinci I., Flowers L., Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol 2008, 109(May (2 Suppl.)):S22-S30.
7. Brown R.E., Breugelmans J.G., Theodoratou D., Benard S. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin 2006, 22(April (4)):663-670.
8. Seoud M., Tjalma W.A., Ronsse V. Cervical adenocarcinoma: moving towards better prevention. Vaccine 2011, 29(November (49)):9148-9158.
9. Cutts F.T., Franceschi S., Goldie S., Castellsague X., de Sanjose S., Garnett G., et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 2007, 85(September (9)):719-726.
10. Schiffman M., Wacholder S. Success of HPV vaccination is now a matter of coverage. Lancet Oncol 2012, 13(January (1)):10-12.
11. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367(9518):1247-1255.
12. Bosch F.X., Tsu V., Vorsters A., Van Damme P., Kane M.A. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases. Vaccine 2012, 30(November (Suppl. 5)):F1-F11.
13. Kohli M., Ferko N., Martin A., Franco E.L., Jenkins D., Gallivan S., et al. Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer 2007, 96(January (1)):143-150.
14. Goldie S.J., O'Shea M., Campos N.G., Diaz M., Sweet S., Kim S.Y. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 2008, 26(July (32)):4080-4093.
15. Laz T.H., Rahman M., Berenson A.B. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 2012, 30(May (24)):3534-3540.
16. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13 through 17 years - United States 2010. MMWR 2011, 60.
17. Dorleans F., Giambi C., Dematte L., Cotter S., Stefanoff P., Mereckiene J., et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010, 15(47).
18. Limia A., Pachon I. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill 2011, 16(21).
19. Information Services, NHS National Services Scotland. Human papilloma virus (HPV) Immunisation uptake rates. Year 3 of the HPV Immunisation Programme (2010/11) publication date - 22 September 2011.
20. Annual HPV vaccine coverage in England in 2009/2010. Department of Health. 27 January 2011 (15439).
21. Rondy M., van Lier A., van de Kassteele J., Rust L., de Melker H. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine 2010, 28(February (9)):2070-2075.
22. Fagot J.P., Boutrelle A., Ricordeau P., Weill A., Allemand H. HPV vaccination in France: uptake, costs and issues for the National Health Insurance. Vaccine 2011, 29(April (19)):3610-3616.
23. Kessels S.J., Marshall H.S., Watson M., Braunack-Mayer A.J., Reuzel R., Tooher R.L. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012, 30(May (24)):3546-3556.
24. Immunise Australia Program - Human papillomavirus (HPV) [accessed January 2013]. http://www.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-hpv.
25. Financing HPV vaccination in developing countries. Lancet 2011, 377(May 9777):1544.
26. LaMontagne D.S., Barge S., Le N.T., Mugisha E., Penny M.E., Gandhi S., et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011, 89(November (11)):30B-821B.
27. Binagwaho A, Wagner C, Gatera M, Karema C, Nutt C, Ngabo F. Achieving high coverage in Rwanda's National Human papillomavirus vaccination programme. Bulletin of the World Health Organization 2012 (published online May 23rd).
28. Smith P.J., Humiston S.G., Marcuse E.K., Zhao Z., Dorell C.G., Howes C., et al. Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the health belief model. Public Health Rep 2011, 126(Suppl. 2):135-146.
29. Johnson D.R., Nichol K.L., Lipczynski K. Barriers to adult immunization. Am J Med 2008, 121(July (7 Suppl. 2)):S28-S35.
30. Cavazos-Rehg P.A., Krauss M.J., Spitznagel E.L., Schootman M., Bucholz K.K., Peipert J.F., et al. Age of sexual debut among US adolescents. Contraception 2009, 80(August (2)):158-162.
31. Chan Z.C., Chan T.S., Ng K.K., Wong M.L. A systematic review of literature about women's knowledge and attitudes toward human papillomavirus (HPV) vaccination. Public Health Nurs 2012, 29(November (6)):481-489.
32. Hilton S., Hunt K., Bedford H., Petticrew M. School nurses' experiences of delivering the UK HPV vaccination programme in its first year. BMC Infect Dis 2011, 11:226.
33. Chan S.S., Yan Ng B.H., Lo W.K., Cheung T.H., Hung Chung T.K. Adolescent girls' attitudes on human papillomavirus vaccination. J Pediatr Adolesc Gynecol 2009, 22(2):85-90.
34. Brabin L., Roberts S.A., Farzaneh F., Kitchener H.C. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006, 24(April (16)):3087-3094.
35. Liddon N.C., Hood J.E., Leichliter J.S. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth. Vaccine 2012, 30(March (16)):2676-2682.
36. Trim K., Nagji N., Elit L., Roy K., Parental Knowledge Attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int 2012, 2012:921236.
37. Schuler C.L., Reiter P.L., Smith J.S., Brewer N.T. Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect 2011, 87(June (4)):349-353.
38. Dahlstrom L.A., Tran T.N., Lundholm C., Young C., Sundstrom K., Sparen P. Attitudes to HPV vaccination among parents of children aged 12-15 years - a population-based survey in Sweden. Int J Cancer 2010, 126(January (2)):500-507.
39. Tozzi A.E., Ravà L., Stat D., Pandolfi E., Marino M.G., Ugazio A.G. Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program. Vaccine 2009, 27(19):2625-2629.
40. Zimet G.D., Mays R.M., Winston Y., Kee R., Dickes J., Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000, 9(1):47-50.
41. Jones M., Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am coll health 2008, 57(1):23-32.
42. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45(5):453-462.
43. Gerend M.A., Lee S.C., Shepherd J.E. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007, 34(July (7)):468-471.
44. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(January (5)):890-895.
45. Rosenthal S.L., Rupp R., Zimet G.D., Meza H.M., Loza M.L., Short M.B., et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008, 43(3):239-245.
46. Dempsey A., Cohn L., Dalton V., Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28(January (4)):989-995.
47. Davis K., Dickman E.D., Ferris D., Dias J.K. Human papillomavirus vaccine acceptability among parents of 10-15-year-old adolescents. J Low Genit Tract Dis 2004, 8(July (3)):188-194.
48. Read D.S., Joseph M.A., Polishchuk V., Suss A.L. Attitudes and perceptions of the HPV vaccine in Caribbean and African-American adolescent girls and their parents. J Pediatr Adolesc Gynecol 2010, 23(August (4)):242-245.
49. Joseph N.P., Clark J.A., Bauchner H., Walsh J.P., Mercilus G., Figaro J., et al. Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women. Women's health issues: official publication of the Jacobs Institute of Women's Health 2012, 22(November-December (6)):e571-e579.
50. Jaspers L., Budiningsih S., Wolterbeek R., Henderson F.C., Peters A.A. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine 2011, 29(October (44)):7785-7793.
51. Chow S.N., Soon R., Park J.S., Pancharoen C., Qiao Y.L., Basu P., et al. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 2010, 28(May (22)):3809-3817.
52. Wong L.P. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural Southeast Asian women. Int J behav med 2011, 18(June (2)):105-111.
53. Becker-Dreps S., Otieno W.A., Brewer N.T., Agot K., Smith J.S. HPV vaccine acceptability among Kenyan women. Vaccine 2010, 28(July (31)):4864-4867.
54. Rositch A.F., Gatuguta A., Choi R.Y., Guthrie B.L., Mackelprang R.D., Bosire R., et al. Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS ONE 2012, 7(7):e40766.
55. Remes P., Selestine V., Changalucha J., Ross D.A., Wight D., de Sanjose S., et al. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 2012, 30(August (36)):5363-5367.
56. Watson-Jones D., Tomlin K., Remes P., Baisley K., Ponsiano R., Soteli S., et al. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS ONE 2012, 7(10):e45231.
57. Madhivanan P., Krupp K., Yashodha M.N., Marlow L., Klausner J.D., Reingold A.L. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine 2009, 27(August (38)):5203-5208.
58. Basu P., Mittal S. Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. J Obstet Gynaecol Res 2011, 37(May (5)):393-401.
59. Moreira E.D., de Oliveira B.G., Neves R.C., Costa S., Karic G., Filho J.O. Assessment of knowledge and attitudes of young uninsured women toward human papillomavirus vaccination and clinical trials. J Pediatr Adolesc Gynecol 2006, 19(April (2)):81-87.
60. Han C.S., Ferris D.G., Waller J., Tharp P., Walter J., Allmond L. Comparison of knowledge and attitudes toward human papillomavirus, HPV vaccine, pap tests, and cervical cancer between US and Peruvian women. J Low Genit Tract Dis 2012, 16(April (2)):121-126.
61. Rama C.H., Villa L.L., Pagliusi S., Andreoli M.A., Costa M.C., Aoki A.L., et al. Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in Sao Paulo, Brazil - a cross-sectional study. BMC women's health 2010, 10:35.
62. Arrossi S., Maceira V., Paolino M., Sankaranarayanan R. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Vaccine 2012, 30(March (14)):2467-2474.
63. Vadaparampil S.T., Kahn J.A., Salmon D., Lee J.H., Quinn G.P., Roetzheim R., et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011, 29(November (47)):8634-8641.
64. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006, 118(December (6)):2280-2289.
65. Hopkins T.G., Wood N.J., West R.M., Darling J.C. UK health professionals' attitudes and knowledge regarding human papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health 2009, 45(November (11)):652-655.
66. Lutringer-Magnin D., Kalecinski J., Barone G., Leocmach Y., Regnier V., Jacquard A.C., et al. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine 2011, 29(July (32)):5322-5328.
67. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126(September (3)):425-433.
68. Krupp K., Marlow L.A., Kielmann K., Doddaiah N., Mysore S., Reingold A.L., et al. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. J Adolesc Health 2010, 46(April (4)):379-384.
69. Tan J., Farrell L., Allen D.G. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey. Aust N Z J Obstet Gynaecol 2010, 50(5):472-477.
70. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005, 37(December (6)):502-510.
71. Duval B., Gilca V., Boulianne N., Pielak K., Halperin B., Simpson M.A., et al. Cervical cancer prevention by vaccination: nurses' knowledge, attitudes and intentions. J Adv Nurs 2009, 65(March (3)):499-508.
72. Mammas I., Stewart J., Hughes A. Human papillomavirus vaccination and school nurses: a British survey. Int J STD AIDS 2010, 21(January (1)):73.
73. Stretch R., McCann R., Roberts S.A., Elton P., Baxter D., Brabin L. A qualitative study to assess school nurses' views on vaccinating 12-13 year old school girls against human papillomavirus without parental consent. BMC Public Health 2009, 9:254.
74. Saraiya M., Rosser J.I., Cooper C.P. Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Womens Health (Larchmt) 2012, 21(February (2)):111-117.
75. Brotherton J.M., Leask J., Jackson C., McCaffery K., Trevena L.J. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sexual health 2010, 7(September (3)):291-298.
76. Ko E.M., Missmer S., Johnson N.R. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 2010, 14(October (4)):339-345.
77. de Carvalho N.S., Teixeira L.M., Pradel E.M., Gabardo J., Joly C., Urbanetz A.A. Vaccinating against HPV: physicians' and medical students' point of view. Vaccine 2009, 27(May (20)):2637-2640.
78. Pandey D., Vanya V., Bhagat S., Vs B., Shetty J. Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PLoS ONE 2012, 7(7):e40619.
79. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in Saudi Arabia. Summary Report 2010, available at [accessed January 2012]. http://www.who.int/hpvcentre.
80. Sait K.H. Knowledge and attitudes, and practices regarding cervical cancer screening among physicians in the Western Region of Saudi Arabia. Saudi Med J 2011, 32(November (11)):1155-1160.
81. Phianmongkhol Y., Suwan N., Srisomboon J., Kietpeerakool C. Knowledge about human papillomavirus infection and cervical cancer prevention among nurses in Chiang Mai University Hospital, Thailand. Asian Pacific journal of cancer prevention: APJCP 2011, 12(3):823-825.
82. Beydag K.D. Knowledge and applications of the midwives and nurses at an educational hospital on the early diagnosis of cervix cancer. Asian Pac J Cancer Prev 2011, 12(2):481-485.
83. Ali S.F., Ayub S., Manzoor N.F., Azim S., Afif M., Akhtar N., et al. Knowledge and awareness about cervical cancer and its prevention amongst interns and nursing staff in Tertiary Care Hospitals in Karachi, Pakistan. PLoS ONE 2010, 5(6):e11059.
84. Houweling H., Spaendonck M.C., Paulussen T., Verweij M., Ruitenberg E.J. Preparing for the next public debate: universal vaccination against hepatitis B. Vaccine 2011, 29(November (48)):8960-8964.
85. de Kok I.M., Habbema J.D., Mourits M.J., Coebergh J.W., van Leeuwen F.E. Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands. Ned Tijdschr Geneeskd 2008, 152(September (37)):2001-2004.
86. van der Noordaa J., Houweling H. Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme. Ned Tijdschr Geneeskd 2008, 152(October (42)):2267-2269.
87. Porter, R. How safe is the cervical cancer jab? Five teenagers reveal their alarming stories, Daily Mail. April 5th 2009 [accessed May 2012]. http://www.dailymail.co.uk/health/article-1167803.
88. Ouedraogo N., Muller O., Jahn A., Gerhardus A. Human papillomavirus vaccination in Africa. Lancet 2011, 378(July (9788)):315-316.
89. Ladner J., Besson M.H., Hampshire R., Tapert L., Chirenje M., Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health 2012, 12:370.